U.S. markets closed
  • S&P 500

    3,310.11
    +39.08 (+1.19%)
     
  • Dow 30

    26,659.11
    +139.16 (+0.52%)
     
  • Nasdaq

    11,185.59
    +180.72 (+1.64%)
     
  • Russell 2000

    1,561.58
    +18.30 (+1.19%)
     
  • Crude Oil

    36.08
    -0.09 (-0.25%)
     
  • Gold

    1,868.90
    +0.90 (+0.05%)
     
  • Silver

    23.35
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1677
    -0.0073 (-0.62%)
     
  • 10-Yr Bond

    0.8350
    +0.0540 (+6.91%)
     
  • GBP/USD

    1.2925
    -0.0062 (-0.48%)
     
  • USD/JPY

    104.6000
    +0.2990 (+0.29%)
     
  • BTC-USD

    13,489.43
    -53.49 (-0.39%)
     
  • CMC Crypto 200

    264.75
    +22.07 (+9.09%)
     
  • FTSE 100

    5,581.75
    -1.05 (-0.02%)
     
  • Nikkei 225

    23,331.94
    -86.57 (-0.37%)
     

Coronavirus Latest: Wednesday, October 14

The United States Departments of Health, HHS, and DoD have announced an expanded partnership with AstraZeneca to support its development and manufacturing of its coronavirus treatment. This comes as Johnson & Johnson’s and Eli Lilly’s trials remain paused for investigations over safety. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus.

Video Transcript

SEANA SMITH: All right, well, one of the big reasons why coronavirus-- or why United Airlines has been having such a tough time is clearly because of the coronavirus. So let's get to the latest on the pandemic.

We have the daily count for new coronavirus cases climbing back above 50,000. This also comes as the hospitalization rate reaches its highest level since August. For more on this, we have Anjalee Khemlani. Anjalee.

ANJALEE KHEMLANI: Thanks, Seana. Yeah, so, you know, we've heard a lot about the coming second wave. And we are starting to see those numbers really prove-- I believe one of the experts on Twitter yesterday was saying there are now more states that are not seeing a second wave than are. So definitely keeping an eye on those numbers.

And we know that we've seen, you know, the concerning pauses in the trials when we're talking about AstraZeneca, as well as now Johnson & Johnson in vaccines, and in addition to that, Eli Lilly with their antibody treatment.

So all in all, put together, you know, on one hand, signaling to those who are concerned that there was too much going on, too much of a rush, this pause has, in fact, given many experts a sigh of relief to see that there is, in fact, safety protocol being followed.

But all of these trials that have now been paused really throws into question the timeline. So they have said that they are sticking to them. It remains a question of whether or not anything will be disrupted or what will happen to emergency use authorization filing, such as the one from Eli Lilly. So all in all, stay tuned. As of right now, a lot still happening.